AVADEL PHARMACEUTICALS PLC (AVDL) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	50.7	71.7	9.8	9.3	16.6	39.2	65.1	39.8
Short-term investments	106.5	149.7	54.4	90.6	77.5	115.0	79.7	53.1
Accounts receivable, net			8.3	11.3	14.8	17.8	7.5	1.7
Inventories			3.6	4.8	6.2	3.3	3.7	6.7
Other current assets	35.3	42.1	6.4	8.8	9.0	5.9	10.4	11.1
Total current assets	192.5	263.5	82.4	124.9	124.0	181.2	166.4	112.3
Property, plant, and equipment, net	0.3	0.4	0.5	1.9	3.0	3.3	2.6	1.8
Intangibles			0.8	1.6	92.3	22.8	15.8	28.4
Goodwill	16.8	16.8	18.5	18.5	18.5	18.5	18.5	18.5
Other fixed assets	33.8	24.9	39.3	36.1	10.2	7.5	0.2	0.1
Total assets	247.3	311.6	151.4	190.3	253.3	245.5	215.1	174.2

Accounts payable	7.7	2.9	6.1	3.5	7.5	7.1	5.0	8.0
Accrued expenses	7.2	6.5	19.8	21.7	50.9	17.2	9.3	43.7
Current portion of long-term debt	0.0	0.0	0.0	0.1	0.1	0.3	0.4	2.4
Current portion of long-term debt				0.1	0.1	0.3	0.4	2.4
Deferred revenues						2.2	5.1	1.3
Other current liabilities	6.2	5.7	10.1	13.1	28.0	35.6	25.3	15.4
Total current liabilities	21.0	15.1	36.0	38.4	86.5	62.4	45.2	70.8
Long-term debt	142.4	128.2	121.7	115.7	0.2	0.5	0.7	1.3
Other liabilities	5.6	6.1	23.0	33.4	81.0	140.4	100.0	77.2
Total liabilities	169.0	149.4	180.6	187.5	167.7	203.4	145.9	149.3

Shareholders' equity [+]	78.2	162.3	-29.2	2.8	85.6	42.1	69.1	24.9
Paid-in capital	549.3	566.9	434.4	433.8	393.5	385.0	364.0	346.6
Retained earnings	-447.8	-384.2	-391.2	-358.0	-262.7	-319.8	-278.5	-320.5
Treasury stock			-50.0	-50.0	-22.4
Tangible shareholders' equity	61.4	145.4	-48.5	-17.3	-25.2	0.7	34.8	-22.0